ARTICLE

Synthesis and Anticancer Activity of 8-Allyl Garcinol

  • Cao Jing ,
  • Han Chaoming ,
  • Zhang Guilian ,
  • Zhou Xinying ,
  • Li Shuwen ,
  • Du Yinduan ,
  • Zhao Shuai ,
  • Zhang Xinyan ,
  • Chen Xin
Expand
  • a School of Pharmaceutical Engineering and Life Science, Changzhou University, Changzhou 213164;
    b Beijing Institute of Dental Research, Beijing Stomatological Hospital, Capital Medical University, Beijing 100050

Received date: 2017-01-09

  Revised date: 2017-03-25

  Online published: 2017-04-10

Supported by

Project supported by the National Natural Science Foundation of China (Nos. 21272029, 81272982).

Abstract

Garcinol, isolated from the fruit rind of Garcinia indica, shows anti-carcinogenic and anti-inflammatory activities. However, the C(8) side chain of garcinol is so large that it may influence the bioactivity of the compound. 8-Allyl garcinol, in which the bulky side chain at C(8) position of garcinol is replaced with much smaller allyl group, was synthesized through a 12-step procedure. Starting from 1,3-cyclohexandione, the key intermediate (±)-1-hydroxy-5,5-dimethyl-4,6-bis(3-methylbut-2-en-1-yl)bicyclo[3.3.1]non-2-ene-3,9-dione (8) was obtained via Effenburger cyclization. Through additional 5-steps, 8-allyl garcinol was prepared. The thiazolyl blue tetrazolium bromide (MTT) results indicated that 8-allyl garcinol shows strong inhibitory activity on cell proliferation of oral cancer cell lines.

Cite this article

Cao Jing , Han Chaoming , Zhang Guilian , Zhou Xinying , Li Shuwen , Du Yinduan , Zhao Shuai , Zhang Xinyan , Chen Xin . Synthesis and Anticancer Activity of 8-Allyl Garcinol[J]. Chinese Journal of Organic Chemistry, 2017 , 37(8) : 2086 -2093 . DOI: 10.6023/cjoc201701017

References

[1] Aggarwal, S.; Das, S. N. Tumor. Biol. 2016, 37, 7175.
[2] Saadat, N.; Gupta, S. V. J. Oncol. 2012, 84, 647206.
[3] Koeberle, A.; Northoff, H.; Werz, O. Biochem. Pharmacol. 2009, 77, 1513.
[4] Li, F.; Shanmugam, M. K.; Siveen, K. S. Oncotarget 2015, 6, 5147.
[5] Wu, A. T.; Lee, W. H.; Huang, C. C.; Lin, C. M.; Huang, Y. J.; Wei, L.;Ting, L. L.; Kuo, C. C.; Hsu, C.; Chiou, J. Biotechnol. Appl. Biochem. 2017, 64, 165.
[6] Liao, C. H.; Sang, S.; Liang, Y. C.; Ho, C. T.; Lin, J. K. Mol. Carcinog. 2004, 41, 140.
[7] Padhye, S.; Ahmad, A.; Oswal, N.; Sarkar, F. C. J. Hematol. Oncol. 2009, 2, 38.
[8] Tanaka, T.; Kohno, H.; Shimada, R.; Kagami, S.; Yamaguchi, F.; Kataoka, S.; Ariga, T.; Murakami, A.; Koshimizu, K.; Ohigashi, H. Carcinogenesis 2000, 21, 1183.
[9] Hong, J.; Sang, S.; Park, H. J.; Kwon, S. J.; Suh, N.; Huang, M. T.; Ho, C. T.; Yang, C. S. Carcinogenesis 2006, 27, 278.
[10] Ahmad, A.; Wang, Z.; Ali, R.; Maitah, M. Y.; Kong, D.; Banerjee, S.; Padhye, S.; Sarkar, F. H. J. Cell. Biochem. 2010, 109, 1134.
[11] Balasubramanyam, K.; Altaf, M.; Varier, R. A.; Swaminathan, V. Ravindran, A.; Sadhale, P. P.; Kundu, T. K. J. Biol Chem. 2004, 279, 33716.
[12] Ahmad, A.; Sarkar, S. H.; Aboukameel A.; Ali, S.; Biersack, B.; Seibt, S.; Li, Y. W.; Bao, B.; Kong, D.; Banerjee, S.; Schobert, R.; Padhye, S. B.; Sarkar, F. H. Carcinogenesis 2012, 33, 2450.
[13] Chen, X.; Zhang, X. Y.; Lu, Y.; Shim, J. Y.; Sang, S.; Sun, Z.; Chen, X. X. Nutr. Cancer. 2012, 64, 1211.
[14] Han, C. M.; Zhou, X. Y.; Cao, J.; Zhang, X. Y.; Chen, X. Bioorg. Chem. 2015, 60, 123.
[15] Socolsky, C.; Plietker, B. Chem.-Eur. J. 2015, 21, 3053.
[16] Biber, N.; Plietker, B.; Mows, K. Nat. Chem. 2011, 3, 938.
[17] Rodeschini, V.; Ahmad, N. M.; Simpkins, N. S. Org. Lett. 2006, 8, 5283.
[18] Nuhant, P.; David, M.; Pouplin, T.; Delpech, B.; Marazano, C. Org. Lett. 2007, 9, 287.
[19] Peng, P.; Linseis, L.; Winter, F. R.; Schmidt, R. R. J. Am. Chem. Soc. 2016, 138, 6002.

Outlines

/